Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study. (September 2022)
- Record Type:
- Journal Article
- Title:
- Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study. (September 2022)
- Main Title:
- Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study
- Authors:
- Chandramouleeshwaran, Susmita
Ghazala, Zaid
Nobrega, José N
Raymond, Roger
Gambino, Sara
Pollock, Bruce G.
Rajji, Tarek K - Abstract:
- Background: A new cell-based serum anticholinergic activity (cSAA) assay that measures anticholinergic activity specifically at muscarinic M1 receptors and eliminates many of the drawbacks of the existing assay was developed by our team. Aims: We aimed to study the relationship between changes in working memory and executive function with changes in cSAA using the new assay in cognitively healthy older adults. Methods: Cognitively healthy participants aged 50 years and above, received a single dose of 0.4 mg of intravenous scopolamine. Cognition and cSAA levels were measured before and 30 min after receiving scopolamine. Cognition was measured using the Cambridge Neuropsychological Test Automated Battery. Results: Ten participants were recruited, and nine (mean age = 69.8, SD = 9.5, range 59–86 years) completed the study. Following scopolamine, participants experienced an increase in cSAA (cSAA pre = 0.90 ± 0.97 vs cSAA post = 12.0 ± 3.70 pmol/L; t -test ( df = (8) = −9.5, p < 0.001). In addition, there was an association between change in cSAA and changes in working memory (Spearman's ρ = 0.68, p = 0.042) and executive function (Spearman's ρ = 0.72, p = 0.027). Conclusions: In our sample of cognitively healthy older adults, the new cSAA assay was able to quantify the scopolamine induced increase in anticholinergic load which correlated significantly with the observed decline in working memory and executive function.
- Is Part Of:
- Journal of psychopharmacology. Volume 36:Number 9(2022)
- Journal:
- Journal of psychopharmacology
- Issue:
- Volume 36:Number 9(2022)
- Issue Display:
- Volume 36, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 36
- Issue:
- 9
- Issue Sort Value:
- 2022-0036-0009-0000
- Page Start:
- 1070
- Page End:
- 1076
- Publication Date:
- 2022-09
- Subjects:
- Cognition -- anticholinergic burden -- cell-based serum anticholinergic assay -- elderly -- scopolamine
Psychopharmacology -- Periodicals
615.78 - Journal URLs:
- http://jop.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/02698811221122019 ↗
- Languages:
- English
- ISSNs:
- 0269-8811
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23525.xml